Kyobo Life to sell maiden won-denominated hybrid bond next month Hybrid bond sale likely to help improve insurer's financial structure
Translated by Kim So-in 공개 2021-08-23 08:13:42
이 기사는 2021년 08월 20일 08시01분 thebell에 표출된 기사입니다
Kyobo Life Insurance plans to raise as much as 500 billion won ($425 million) from its maiden won-denominated hybrid bond sale to improve its financial structure.Kyobo Life and its bookrunners, KB Securities and Korea Investment & Securities, are preparing to issue a hybrid bond to secure liquidity, industry sources said on Wednesday. The issuer is expected to start a book building process and issue the bond in mid-September.
The issuer has tentatively decided to raise 300 billion won through the issuance. The amount could be increased to 500 billion won if the bond is oversubscribed during the book building process in early September.
This will be the life insurer’s first offering of a hybrid bond, which is regarded as an asset, instead of debt, in financial statements.
Kyobo Life has issued mezzanine debts whenever it needed to secure liquidity and improve the financial structure. In July 2017, the life insurer raised about $500 million in its offering of a foreign currency-denominated hybrid bond. It was the first time a domestic life insurer sold a hybrid bond in the Korean paper market. Korean paper refers to foreign currency debt issued by South Korean entities abroad. The bond was underwritten by Citigroup Global Markets Korea Securities, JP Morgan, Nomura Securities, and UBS.
Kyobo Life plans to use the proceeds from the issuance to repay borrowings and increase its capital base, as its total capital decreased from 12.9 trillion won on a consolidated basis at the end of last year to 11.9 trillion won at the end of June this year. (Reporting by Chul Kang)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- 크레센도, HPSP 리캡 'LP 중간회수·제값받기' 포석
- [IR Briefing]제이엘케이, "4분기부터 해외 매출 인식 본격화"
- [i-point]엔켐, 프랑스 덩케르크와 서유럽 전해액 생산기지 구축
- [인투셀 IPO]상단에 모인 투심, ADC 상승세 이어간다
- AI 협력 늘리는 포바이포, 이스트소프트와 '맞손'
- 신테카바이오, 미국 OCMS Bio와 '혁신 항체신약 파이프라인 공동개발'
- [i-point]엔젤로보틱스, LIG넥스원과 국방용 웨어러블 로봇 개발 협력
- [i-point]에이스엔지니어링, 미국 EPC Power와 전략적 파트너십
- [DS금융그룹 시대 개막]'LP 엑시트' 절호의 타이밍, '장덕수 회장' 재정비 결단
- 유언대용신탁 개발 나섰던 신한증권…하반기 중 출시 전망